Diffuse Optical Tomography in Prostate Cancer Detection and Risk Stratification - A Pilot Study

Protocol: 
AAAL3709
Phase: 
Pilot

Diffuse Optical Tomography in Prostate Cancer Detection and Risk Stratification - A Pilot Study

This study is looking to see if a new device, diffuse optical tomography (DOT), can detect prostate cancer. We will also see if DOT can tell the difference between high risk and low risk prostate cancers. DOT uses light to collect more information about the prostate. The examination using DOT is investigational.

Are you Eligible? (Inclusion Criteria)

Patients diagnosed with prostate cancer who are scheduled to undergo surgical removal of their prostate are eligible for this study.

Specialty Area(s)

Trial Location

Herbert Irving Comprehensive Cancer Center
161 Fort Washington Ave.
Herbert Irving Pavilion
New York, NY 10032
United States